Highlights and Quick Summary
- EBIT Growth for the quarter ending September 30, 2023 was 0.17 (a -134.17% decrease compared to previous quarter)
- Year-over-year quarterly EBIT Growth decreased by -15.16%
- Annual EBIT Growth for 2022 was -0.42 (a -91.01% decrease from previous year)
- Annual EBIT Growth for 2021 was -4.66 (a 314.62% increase from previous year)
- Annual EBIT Growth for 2020 was -1.12 (a -312.31% decrease from previous year)
- Twelve month EBIT Growth ending September 30, 2023 was 0.0 (a -100.37% decrease compared to previous quarter)
- Twelve month trailing EBIT Growth decreased by -100.1% year-over-year
Trailing EBIT Growth for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| 0.0 | -0.11 | -0.1 | -0.42 |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBIT Growth of Absci Corporation
Most recent EBIT Growthof ABSI including historical data for past 10 years.Interactive Chart of EBIT Growth of Absci Corporation
Absci Corporation EBIT Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.17 | -0.49 | 0.15 | – | – |
| 2022 | 0.2 | -0.32 | -0.73 | -1.58 | -0.42 |
| 2021 | -4.67 | -5.28 | -4.93 | -3.48 | -4.66 |
| 2020 | 0.82 | 0.84 | 0.83 | 0.78 | -1.12 |
| 2019 | – | – | – | – | 0.53 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology